Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

NCT06003231

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Glendale, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Mesa, Arizona, United States
View all 96 locations
View Trial Details
Active, Not Recruiting

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

NCT01933932

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Pembroke Pines, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 197 locations
View Trial Details
Active, Not Recruiting

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

NCT06472076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Ocala, Florida, United States
  • GSK Investigational Site Honolulu, Hawaii, United States
  • GSK Investigational Site Lexington, Kentucky, United States
  • GSK Investigational Site Lexington, Kentucky, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

NCT06074588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica ( Site 0023) Los Angeles, California, United States
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0001) Jacksonville, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0005) Orange City, Florida, United States
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0003) Marietta, Georgia, United States
View all 194 locations
View Trial Details
Active, Not Recruiting

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

NCT03043872

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Rogers, Arkansas, United States
  • Research Site Santa Monica, California, United States
View all 207 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

NCT03456076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • MGH Cancer Center Boston, Massachusetts, United States
  • AHN Cancer Institute ? Allegheny General Hospital Pittsburgh, Pennsylvania, United States
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
View all 114 locations
View Trial Details
Active, Not Recruiting

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

NCT02734004

Conditions
Adnexal Diseases, Breast, Breast Diseases, +34 more
Locations
  • Research Site Newnan, Georgia, United States
  • Research Site Towson, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Detroit, Michigan, United States
View all 47 locations
View Trial Details

Related conditions